Home › Funds › Artia Global Partners LP › SRRK
Artia Global Partners LP position in SRRK
SCHOLAR ROCK HLDG CORP · Health Care
Artia Global Partners LP reported holding 96,285 shares of SRRK (SCHOLAR ROCK HLDG CORP) in its Q2 2026 13F filing — a position valued at US$5.3M, representing 0.98% of its reported portfolio and ranking #25 among its reported holdings. Artia Global Partners LP has disclosed SRRK holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's SRRK position evolved
Artia Global Partners LP first disclosed a stake in SRRK in Q1 2025 at 172,185 shares (US$5.5M). Across 6 filings, Artia Global Partners LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 96,285 shares valued at US$5.3M. Notable position changes include a 27% trim in Q2 2025 (shares rose 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 172.19K | $5.54M | New |
| Q2 2025 | 126.28K | $4.47M | Reduce |
| Q3 2025 | 96.28K | $3.59M | Reduce |
| Q4 2025 | 96.28K | $4.24M | Hold |
| Q1 2026 | 96.28K | $4.73M | Hold |
| Q2 2026 | 96.28K | $5.30M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRRK and 13F data
SRRK (SCHOLAR ROCK HLDG CORP) is a Health Care company. 54 other funds we track also report a position in SRRK — the largest reported positions include Siren, L.L.C. (US$526.6M), Samsara BioCapital, LLC (US$379.4M), Orbis Allan Gray Ltd (US$326.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRRK
- Siren, L.L.C. 9.58M sh · $526.63M · Q2 2026
- Samsara BioCapital, LLC 6.90M sh · $379.37M · Q2 2026
- Orbis Allan Gray Ltd 5.93M sh · $326.34M · Q2 2026
- Redmile Group, LLC 4.31M sh · $237.11M · Q2 2026
- Bellevue Group AG 2.45M sh · $134.73M · Q2 2026
- Hood River Capital Management LLC 2.22M sh · $122.36M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 2.21M sh · $121.31M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 2.11M sh · $116.13M · Q2 2026
- Integral Health Asset Management, LLC 750.00K sh · $41.25M · Q2 2026
- Rock Springs Capital Management LP 715.45K sh · $39.35M · Q2 2026
- Casdin Capital 665.00K sh · $36.58M · Q2 2026
- Eagle Health Investments LP 555.27K sh · $30.54M · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held SRRK?
Artia Global Partners LP has disclosed SRRK holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Artia Global Partners LP's current position in SRRK?
As of Q2 2026, Artia Global Partners LP holds 96.28K shares of SRRK (SCHOLAR ROCK HLDG CORP), valued at $5.30M, representing 0.98% of its reported portfolio and ranking #25.
Has Artia Global Partners LP been buying or selling SRRK?
In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in SRRK.
Which other funds hold SRRK?
Other major institutional holders of SRRK include Siren, L.L.C., Samsara BioCapital, LLC, Orbis Allan Gray Ltd, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.